Skip to main content
OpenTrials

Clinical trial condition

Non-Squamous Non-Small Cell Lung Cancer

Explore clinical trials studying Non-Squamous Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

69 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Non-Squamous Non-Small Cell Lung Cancer trial results

Completed

A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

NCT01174563

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Haemek Hospital; Oncology Afula, Israel
  • Barzilai; Oncology Ashkelon, Israel
  • Soroka Medical Center; Oncology Dept Beersheba, Israel
  • Carmel Hospital; Oncology Unit Haifa, Israel
View all 16 locations
View Trial Details
Completed

A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

NCT01310036

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Princess Margaret Hospital; Oncology Hong Kong
  • Queen Elizabeth Hospital; Clinical Oncology Hong Kong
  • Prince of Wales Hosp; Dept. Of Clinical Onc Shatin, Hong Kong
  • Seoul National University Bundang Hospital Gyeonggi-do, South Korea
View all 22 locations
View Trial Details
Completed

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice

NCT01893268

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Clinique Du Docteur Calabet; Cromg Agen, France
  • Ch Du Pays D Aix; Pneumologie Aix-en-Provence, France
  • Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire Aix-en-Provence, France
  • Cabinet Medical Amiens, France
View all 88 locations
View Trial Details
Completed

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)

NCT01378962

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale; Oncologia Medica A Naples, Campania, Italy
  • Ospedale Bellaria; U.O. Oncologia Medica Bologna, Emilia-Romagna, Italy
  • A.O. Universitaria Policlinico Di Modena; Ematologia Modena, Emilia-Romagna, Italy
  • Istituto Regina Elena; Oncologia Medica A Rome, Lazio, Italy
View Trial Details
Completed

A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

NCT01995188

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
  • The University of Oklahoma Oklahoma City, Oklahoma, United States
  • The Sarah Cannon Research Inst Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

NCT01351415

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • USA Mitchell Cancer Institute Mobile, Alabama, United States
  • Palo Verde Hema/Onc Glendale, Arizona, United States
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Clopton Clinic Jonesboro, Arkansas, United States
View all 179 locations
View Trial Details
Completed

ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations

NCT01723878

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Hospital Virgen de los Lirios; Servicio de Oncologia Alcoy, Alicante, Spain
  • Hospital Universitario Son Espases; Servicio de Oncologia Palma de Mallorca, Balearic Islands, Spain
  • Hospital Son Llatzer; Servicio de Oncologia Palma de Mallorca, Balearic Islands, Spain
  • Hospital General de Granollers; Servicio de Oncologia Granollers, Barcelona, Spain
View all 43 locations
View Trial Details

Related conditions